1. Intravenous Acetaminophen vs Intravenous Diclofenac Sodium in Management of Skeletal Vaso-occlusive Crisis Among Children with Homozygous Sickle Cell Disease: A Randomized Controlled Trial
- Author
-
Smita Kumari Panda, Prakash Chandra Panda, Nihar Ranjan Mishra, Chandra Sekhar Patra, and Bijan Kumar Nayak
- Subjects
medicine.medical_specialty ,Diclofenac ,Anemia, Sickle Cell ,Disease ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Double-Blind Method ,Randomized controlled trial ,law ,030225 pediatrics ,Pediatric surgery ,medicine ,Humans ,Single-Blind Method ,030212 general & internal medicine ,Child ,Acetaminophen ,Pain Measurement ,business.industry ,Intravenous acetaminophen ,Diclofenac Sodium ,medicine.disease ,stomatognathic diseases ,Anesthesia ,Pediatrics, Perinatology and Child Health ,business ,Vaso-occlusive crisis ,medicine.drug - Abstract
To compare the efficacy of intravenous acetaminophen and intravenous diclofenac sodium in the management of skeletal vaso-occlusive crisis among children with sickle cell disease. Single blind randomized controlled trial. Tertiary care hospital. 104 children with sickle cell disease and skeletal vaso-occlusive crisis. Intravenous acetaminophen at 10mg/kg/dose 8 hourly and intravenous diclofenac sodium at 1mg/kg/dose 8 hourly in 1:1 ratio. Reduction in pain score (50%), number of doses needed to relieve pain after 24 hours of drug administration and decrease in pain score at 1 hour. A 50% reduction in pain score was seen in 35 (77.3%) and 10 (21.7%) children among acetaminophen and diclofenac sodium groups respectively (RR, 95% CI 3.6; 2.02–6.33, P< 0.001). The mean (SD) fall in pain score at 1 hour was significantly higher among intervention arm as compared to control arm [1.51 (0.5) and 1.06 (0.5); P
- Published
- 2021
- Full Text
- View/download PDF